| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/22/2023 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to Buy) | 392.5k | $1.60 | $627.9k | | 09/22/2023 |
| 08/23/2023 | Apexigen, Inc. | | Disposition | Stock Option (right to buy) | 100k | $2.65 | $265k | | 08/23/2023 |
| 08/23/2023 | Apexigen, Inc. | | Disposition | Stock Option (right to buy) | 34.1k | $4.59 | $156.4k | | 08/23/2023 |
| 08/23/2023 | Apexigen, Inc. | | Disposition | Stock Option (right to buy) | 20.5k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to buy) | 5.9k | $26.61 | $156.4k | | 08/23/2023 |
| 08/23/2023 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to buy) | 3.5k | $26.61 | $94k | | 08/23/2023 |
| 08/23/2023 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to buy) | 17.2k | $15.37 | $265.1k | | 08/23/2023 |
| 03/02/2023 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5.1k | $3.63 | $18.4k | | 03/02/2023 |
| 11/16/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 3.2k | $4.49 | $14.4k | | 11/16/2022 |
| 11/16/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 1.1k | $4.49 | $5k | | 11/16/2022 |
| 09/29/2022 | Apexigen, Inc. | | Grant | Stock Option (right to buy) | 100k | $2.65 | $265k | | 09/29/2022 |
| 08/16/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 4.1k | $5.03 | $20.8k | | 08/16/2022 |
| 05/17/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 3.9k | $5.32 | $20.6k | | 05/17/2022 |
| 03/01/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 147.6k | $10.21 | $1.5M | | 03/01/2022 |
| 03/01/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 2.2k | $9.86 | $21.9k | | 03/01/2022 |
| 03/01/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 78.5k | $0.00 | $0 | | 03/01/2022 |
| 02/10/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5k | $16.00 | $80k | | 02/10/2022 |
| 02/10/2022 | Atara Biotherapeutics, Inc. | ATRA | Exercise | Employee Stock Option (Right to Buy) | 5k | $9.58 | $47.9k | | 02/10/2022 |
| 01/03/2022 | Atara Biotherapeutics, Inc. | ATRA | Exercise | Employee Stock Option (Right to Buy) | 5k | $9.58 | $47.9k | | 01/03/2022 |
| 01/03/2022 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5k | $16.01 | $80k | | 01/03/2022 |
| 12/01/2021 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5k | $17.94 | $89.7k | | 12/01/2021 |
| 12/01/2021 | Atara Biotherapeutics, Inc. | ATRA | Exercise | Employee Stock Option (Right to Buy) | 5k | $9.58 | $47.9k | | 12/01/2021 |
| 11/16/2021 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 2.2k | $17.12 | $37.6k | | 11/16/2021 |
| 11/02/2021 | Atara Biotherapeutics, Inc. | ATRA | Exercise | Employee Stock Option (Right to Buy) | 5k | $9.58 | $47.9k | | 11/02/2021 |
| 11/02/2021 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5k | $16.41 | $82k | | 11/02/2021 |
| 08/17/2021 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 2.2k | $12.53 | $27k | | 08/17/2021 |
| 05/18/2021 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5.2k | $14.55 | $75.4k | | 05/18/2021 |
| 03/01/2021 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 53.9k | $0.00 | $0 | | 03/01/2021 |
| 03/01/2021 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 81.3k | $17.11 | $1.4M | | 03/01/2021 |
| 05/14/2020 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 277.5k | $9.58 | $2.7M | | 05/14/2020 |
| 05/14/2020 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 46.2k | $0.00 | $0 | | 05/14/2020 |
| 02/14/2020 | Gossamer Bio, Inc. | GOSS | Grant | Common Stock | 46.5k | $0.00 | $0 | | 02/14/2020 |
| 02/14/2020 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (right to buy) | 71.5k | $14.55 | $1M | | 02/14/2020 |
| 12/30/2019 | Gossamer Bio, Inc. | GOSS | Exercise | Non-qualified stock option (Right to Buy) | 40k | $10.71 | $428.4k | | 12/27/2019 |
| 12/30/2019 | Gossamer Bio, Inc. | GOSS | Sale | Common Stock | 40k | $15.00 | $600k | | 12/27/2019 |
|